Video Shorts

0:51
Why CAR T Cells are 'Living Drugs' That Grow Inside You
5 months ago
by
Feliza Mirasol(+1 more)

0:26
Solving Complexity in Modern Biopharma Analytics
5 months ago
by
Feliza Mirasol(+1 more)

0:32
A Cure for Type 1 Diabetes? The Future of Cell Therapy
6 months ago
by
Feliza Mirasol(+1 more)

1:00
The Future of Biomanufacturing_ Key Takeaways from INTERPHEX 2026
6 months ago
by
Feliza Mirasol(+3 more)

0:19
Achieving Efficiency in Bioproduction
6 months ago
by
Feliza Mirasol(+1 more)

0:43
Why Cells Are the Ultimate Drug Delivery Platform
6 months ago
by
Feliza Mirasol(+1 more)

0:45
What is the 'Take Home' Strategy for Advanced Therapies?
6 months ago
by
Feliza Mirasol(+1 more)

0:48
Why Biotech Startups Fail: The 'Begin with the End in Mind' Strategy
6 months ago
by
Feliza Mirasol(+1 more)

0:30
Why the Need for a Risk-Based Cleaning Strategy Approach?
6 months ago
by
Feliza Mirasol(+1 more)

0:17
How Can 3 Billion Years of Evolution Fix AI Drug Discovery?
6 months ago
by
Feliza Mirasol(+1 more)

0:21
Is AI Hype or Reality in Manufacturing?
6 months ago
by
Feliza Mirasol(+2 more)

0:15
Beyond the Hype: AI in Pharma
6 months ago
by
Feliza Mirasol(+2 more)

0:42
Bridging Science and Manufacturing: A Critical Partnership
6 months ago
by
Feliza Mirasol(+1 more)

0:26
Why Our Industry Is Becoming Stronger Than Ever
7 months ago
by
Nicholas Jacobus(+1 more)

0:22
Why Pharma is Onshoring Manufacturing Back to North America
7 months ago
by
Nicholas Jacobus(+1 more)

0:43
Why Early Investment is Key to Market Dominance
7 months ago
by
Nicholas Jacobus(+1 more)

1:16
Did You Know? There’s New Technology on the Scene to Tackle Childhood Vision Loss
7 months ago
by
Feliza Mirasol

0:58
1-Minute Fact: There is a Multispecific Revolution in Oncology
7 months ago
by
Feliza Mirasol

1:28
Did You Know? Multispecific Antibodies Are on the Rise
7 months ago
by
Feliza Mirasol

1:00
1-Minute Fact: ADCs Rise as the Oncology Paradigm Shifts
7 months ago
by
Feliza Mirasol

1:42
The New Frontier of Cancer Treatment: Bispecific ADCs
7 months ago
by
Feliza Mirasol

0:46
Streamlining the Path to Phase One Clinical Trials
8 months ago
by
Feliza Mirasol(+1 more)

0:36
Don't Restart Your Trial: Why Exposure Data is Critical
8 months ago

0:36
The Future of Scaling Cell and Gene Therapies
8 months ago
by
Feliza Mirasol(+1 more)

0:33
Why Computer Scientists are the Future of Biopharma
8 months ago
by
Feliza Mirasol(+1 more)

0:48
How Manufacturing Delays Impact Patient Access to Cell Therapies
8 months ago
by
Feliza Mirasol(+1 more)

0:34
The Future of Integrated Bioprocessing & Automation
8 months ago
by
Feliza Mirasol(+1 more)

0:43
Why Early Commercialization Plans Are Crucial for Cell & Gene
8 months ago
by
Feliza Mirasol(+1 more)

0:33
Why Tox Studies are a Strategic Investment in Biotech
8 months ago
by
Feliza Mirasol(+1 more)

0:35
The Most Important Rule for R&D Investment
9 months ago
by
Feliza Mirasol
Advertisement
Advertisement
Trending on BioPharm International
1
BioNTech, BMS to Pair Pumitamig With Trodelvy in Phase 3 First-Line TNBC Trial
2
Treasury Proposes Adding Biotech to Outbound Investment Restrictions Under COINS Act
3
TaiMed’s Anti-CD4 Antibody TMB-365 Reduces HIV Viral Load in Phase 1, Supporting Long-Acting Combination Regimens
4
Zylidac Bio to Scale Prolific's Optogenetic Cell Line Platform to GMP
5
